| scholarly article | Q13442814 |
| P50 | author | Sabine Bahn | Q28469526 |
| Laura W Harris | Q42333833 | ||
| Paul C Guest | Q56613790 | ||
| Pietro Liò | Q59652936 | ||
| P2093 | author name string | Lan Wang | |
| Dan Ma | |||
| Hassan Rahmoune | |||
| Tammy M K Cheng | |||
| Yagnesh Umrania | |||
| Matt T Wayland | |||
| Victoria Stelzhammer | |||
| Yu-En Lu | |||
| P2860 | cites work | Molecular portraits of human breast tumours | Q28032461 |
| Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress | Q28257571 | ||
| Nonlinear Component Analysis as a Kernel Eigenvalue Problem | Q29030435 | ||
| Identification of proteomic changes during differentiation of adult mouse subventricular zone progenitor cells. | Q33269587 | ||
| China's great famine: 40 years later | Q33883816 | ||
| Negative symptoms in patients with schizophrenia with special reference to the primary versus secondary distinction | Q34213178 | ||
| Duration of untreated psychosis: a critical examination of the concept and its importance | Q34220976 | ||
| Advances in schizophrenia | Q34269283 | ||
| Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics | Q34677578 | ||
| The KEGG database. | Q35050215 | ||
| The benefits of microarrays as tools for studying neuropsychiatric disorders. | Q35715644 | ||
| The Metabolic Syndrome in Patients With Severe Mental Illnesses | Q35884715 | ||
| Course and long-term treatment of schizophrenic psychoses | Q35951570 | ||
| Interactions of metabolic hormones, adipose tissue and exercise | Q36128734 | ||
| Metabolic changes in schizophrenia and human brain evolution | Q36955023 | ||
| Modelling prefrontal cortex deficits in schizophrenia: implications for treatment | Q37098591 | ||
| Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. | Q37142617 | ||
| Current status of prognostic profiling in breast cancer | Q37151603 | ||
| Depression in schizophrenia: methodological artifact or distinct feature of the illness? | Q37156552 | ||
| Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer | Q37352434 | ||
| The long term effects of early postnatal diet on adult health. | Q37396339 | ||
| Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. | Q41102243 | ||
| Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients | Q43185085 | ||
| Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand | Q43278384 | ||
| Relapse and impairment in bipolar disorder | Q43514252 | ||
| Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding | Q44707514 | ||
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins | Q44917427 | ||
| Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia | Q44953308 | ||
| Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist | Q46587065 | ||
| 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease | Q46661063 | ||
| Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood | Q48122360 | ||
| Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study | Q48258798 | ||
| Effects of social isolation rearing on the limbic brain: a combined behavioral and magnetic resonance imaging volumetry study in rats | Q48303994 | ||
| Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. | Q48830689 | ||
| Computation with the KEGG pathway database. | Q51647348 | ||
| Neuropsychological function in euthymic patients with bipolar disorder. | Q52029696 | ||
| Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. | Q53185818 | ||
| Does treatment delay in first-episode psychosis really matter? | Q55036321 | ||
| Consensus on early intervention in schizophrenia | Q73147322 | ||
| Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia | Q80024902 | ||
| Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer | Q82242253 | ||
| P433 | issue | 3 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 510-522 | |
| P577 | publication date | 2009-12-10 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Identification of targeted analyte clusters for studies of schizophrenia | |
| P478 | volume | 9 |
| Q37966594 | An integrative functional genomics approach for discovering biomarkers in schizophrenia |
| Q38807041 | Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays |
| Q34113374 | Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia |
| Q36508139 | Identification and validation of urinary metabolite biomarkers for major depressive disorder |
| Q60649880 | Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients |
| Q42872138 | Oxidative stress in schizophrenia: pathogenetic and therapeutic implications |
| Q48334300 | Proteomic analysis of the maternal protein restriction rat model for schizophrenia: identification of translational changes in hormonal signaling pathways and glutamate neurotransmission |
| Q57169146 | Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future |
| Q92070536 | Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways |
| Q34220102 | The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus. |
Search more.